KR100310839B1 - 안정성이 개선된 파크리탁셀 가용화 주사제 조성물 - Google Patents
안정성이 개선된 파크리탁셀 가용화 주사제 조성물 Download PDFInfo
- Publication number
- KR100310839B1 KR100310839B1 KR1019990009929A KR19990009929A KR100310839B1 KR 100310839 B1 KR100310839 B1 KR 100310839B1 KR 1019990009929 A KR1019990009929 A KR 1019990009929A KR 19990009929 A KR19990009929 A KR 19990009929A KR 100310839 B1 KR100310839 B1 KR 100310839B1
- Authority
- KR
- South Korea
- Prior art keywords
- paclitaxel
- polyvinylpyrrolidone
- anhydrous ethanol
- composition
- solubilizer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
공침혼합물 제조 | 폴리비닐피롤리돈/배합양 | 희석 안정성(hr) | |
1:10 | 1:50 | ||
실시예 1실시예 2실시예 3 | K-17/50mgK-17/100mgK-17/150mg | 102020 | 101616 |
실시예 4실시예 5실시예 6 | K-12/50mgK-12/100mgK-12/150mg | 183026 | 122424 |
대비조성물 | 12 | 16 | |
※ 희석 안정성 : 희석 비율에 따른 안정성 |
Claims (2)
- 파크리탁셀 주사제 조성물에 있어서,파크리탁셀 : 30mg(0.6중량%)폴리비닐피롤리돈 : 90~150mg(1.8~3.0중량%)폴리옥시에틸렌(15-20)글리세롤리시노레이트 (가용화제) : 0.5~1.5ml(10~30중량%)솔리솔베이트 80 (보조가용화제) : 0.5~1.0ml(10~20중량%)무수에탄올(용제) : 1.0~2.0ml(20~40중량%)폴리에틸렌글리콜(용제) : 1.0~2.0ml(20~40중량%)의 조성비를 갖으며 파크리탁셀과 폴리비닐피롤리돈을 공침혼합물로 하여 조성한 파크리탁셀 가용화 주사제 조성물.
- 제1항에 있어서, 폴리비닐피롤리돈의 K-치(K-value)가 10~20의 범위에서 선택되는 파크리탁셀 가용화 주사제 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990009929A KR100310839B1 (ko) | 1999-03-23 | 1999-03-23 | 안정성이 개선된 파크리탁셀 가용화 주사제 조성물 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990009929A KR100310839B1 (ko) | 1999-03-23 | 1999-03-23 | 안정성이 개선된 파크리탁셀 가용화 주사제 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20000061113A KR20000061113A (ko) | 2000-10-16 |
KR100310839B1 true KR100310839B1 (ko) | 2001-10-12 |
Family
ID=19577464
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990009929A KR100310839B1 (ko) | 1999-03-23 | 1999-03-23 | 안정성이 개선된 파크리탁셀 가용화 주사제 조성물 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100310839B1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100945741B1 (ko) | 2003-01-16 | 2010-03-05 | 부광약품 주식회사 | 염산아포모르핀을 함유하는 구강스프레이 제제 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100917809B1 (ko) | 2006-05-22 | 2009-09-18 | 에스케이케미칼주식회사 | 우수한 저장안정성을 갖는 도세탁셀 함유 주사제 조성물 |
KR100917810B1 (ko) * | 2006-06-02 | 2009-09-18 | 에스케이케미칼주식회사 | 저장안정성이 우수한 파클리탁셀 함유 주사제 조성물 |
WO2007142440A1 (en) * | 2006-06-02 | 2007-12-13 | Sk Chemicals Co., Ltd. | Stable pharmaceutical composition containing paclitaxel and a method of manufacturing the same |
-
1999
- 1999-03-23 KR KR1019990009929A patent/KR100310839B1/ko not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100945741B1 (ko) | 2003-01-16 | 2010-03-05 | 부광약품 주식회사 | 염산아포모르핀을 함유하는 구강스프레이 제제 |
Also Published As
Publication number | Publication date |
---|---|
KR20000061113A (ko) | 2000-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR0136722B1 (ko) | 택산류 유도체를 기재로한 신규한 조성물 | |
RU2144356C1 (ru) | Композиция для инъекций на основе таксоидов | |
TWI478921B (zh) | 醫藥調配物 | |
AU764626B2 (en) | Pharmaceutical formulations of taxanes | |
DE60031286T2 (de) | Polymere zusammensetzung zur lösung von schwer wasserlöslichen medikamenten und verfahren zu deren herstellung | |
JPH07505628A (ja) | 静脈注射用のラパマイシン製剤 | |
US5616588A (en) | Rapamycin formulation for IV injection | |
KR100810066B1 (ko) | 투명 수용성 마취제 조성물 | |
AT395819B (de) | Wasserloesliche monoester als solubilisatoren fuer pharmakologische wirkstoffe und pharmazeutische hilfsstoffe | |
JP2008542260A (ja) | 新規の注射可能組成物及びその調製方法 | |
US3966918A (en) | Method of preparing aqueous solutions of sterol glycosides and their ester derivatives | |
KR100310839B1 (ko) | 안정성이 개선된 파크리탁셀 가용화 주사제 조성물 | |
EP4218721A1 (en) | Rapamycin (rapa) self-microemulsifying injection and preparation method and use thereof | |
US20070032438A1 (en) | Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions | |
AU762963B2 (en) | Cyclosporin solution | |
KR101612259B1 (ko) | 고농도의 탁산을 포함하는 경구 투여용 약학 조성물 | |
KR100312628B1 (ko) | 안정성이 개선된 파크리탁셀 주사제 조성물 | |
KR100312177B1 (ko) | 안정성이 개선된 파크리탁셀 주사제 조성물 및 그의 제조방법 | |
KR960004019B1 (ko) | 니모디핀의 가용화 방법 | |
JPS6028916A (ja) | アクラルビシンまたはその塩酸塩の油性組成物 | |
DE3830494A1 (de) | Wasserloesliche monoester als solubilisatoren fuer pharmakologische wirkstoffe und pharmazeutische hilfsstoffe | |
RU2481827C2 (ru) | Фармацевтический состав для инъекций, способ его получения и перфузионный раствор на основе фармацевтического состава | |
KR19980083257A (ko) | 비페닐디메칠디카르복실레이트(ddb)의 셀프 마이크로에멀젼 제제 | |
KR20010002463A (ko) | 디메틸아세트아미드(dma)를 사용하여 ddb 를 가용화시키는 방법 | |
KR20060087005A (ko) | 투명한 경구용 이부프로펜 액제 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120703 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20130905 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20140903 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20150712 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20160819 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20170823 Year of fee payment: 17 |
|
FPAY | Annual fee payment |
Payment date: 20180823 Year of fee payment: 18 |
|
EXPY | Expiration of term |